CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19. Issue 6 (December 2022) - Gregersen, Ida
Highlights: CXCL16 correlates to severity of Covid-19. CXCL16 associates with cardiac risk markers. CXCL16 predicts risk of 60 days mortality.